Publications & Preprints

Mallm JP, Windisch P, Biran A, Schumacher S, Poos AM, König R, Herold-Mende C, Meshorer E, Tönjes M, Rippe K. Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to loss of DNA repair capacity  (in prep.).

Eberle JP, Muranyi W, Erfle H & Gunkel M.  Fully Automated Targeted Confocal and Single-Molecule Localization Microscopy. Methods Mol Biol 1663, 139-152. doi: 10.1007/978-1-4939-7265-4_12 | Abstract

Sieverling L, Hong C, Koser SD, Ginsbach P, Kleinheinz K, Hutter B, Braun DM, Cortes-Ciriano I, Xi R, Kabbe R, Park PJ, Eils R, Schlesner M, Rippe K, Jones DTW, Brors B & Feuerbach L (2017). Genomic footprints of activated telomere maintenance mechanisms in cancer. bioRxiv 157560. doi: 10.1101/157560

Graf M, Bonetti D, Lockhart A, Serha K, Kellner V, Maicher A, Jolivet P, Teixeira MT & Luke B (2017). Telomere Length Determines TERRA and R-Loop Regulation through the Cell Cycle. Cell 170, 72-85. doi: 10.1016/j.cell.2017.06.006 | Abstract

Burdelski C, Borcherding L, Kluth M, Hube-Magg C, Melling N, Simon R, et al. (2017). Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer. Oncotarget 8, 31494-508. | Abstract

Braun DM, Chung I, Kepper N & Rippe K (2017). TelNet - a database for human and yeast genes involved in telomere maintenance. bioRxiv 130153. doi: 10.1101/130153

Deeg KI, Chung I, Poos AM, Braun DM, Korshunov A, Oswald M, Keppe, N, Bender S, Castel D, Lichter P, Grill J, Pfister SM, König R, Jones DT & Rippe K (2017). Dissecting telomere maintenance mechanisms in pediatric glioblastoma. bioRxiv 129106. doi: 10.1101/129106

Gunkel M, Eberle JP & Erfle H (2017). Fluorescence-Based High-Throughput and Targeted Image Acquisition and Analysis for Phenotypic Screening. Methods Mol Biol 1563, 269-280.  doi: 10.1007/978-1-4939-6810-7_17 | Abstract

Tektonidis M and Rohr K. (2017) Diffeomorphic Multi-Frame Non-Rigid Registration of Cell Nuclei in 2D and 3D Live Cell Images, IEEE Trans Image Process 26, 1405-1417. doi: 10.1109/TIP.2017.2653360 | Abstract

Gunkel M, Chung I, Wörz S, Deeg KI, Simon R, Sauter G, Jones DT, Korshunov A, Rohr K, Erfle H & Rippe K (2017). Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow. Methods 114, 60-73. doi: 10.1016/j.ymeth.2016.09.014 | Abstract

Melling N, Rashed M, Schroeder C, Hube-Magg C, Kluth M, Lang D, et al. (2017). High-Level gamma-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer. Int J Mol Sci 18, E286. doi: 10.3390/ijms18020286 | Abstract

Kluth M, Amschler NN, Galal R, Moller-Koop C, Barrow P, Tsourlakis MC, et al. (2017). Deletion of 8p is an independent prognostic parameter in prostate cancer. Oncotarget 8, 379-92. | Abstract

Wilczak W, Rashed S, Hube-Magg C, Kluth M, Simon R, Buscheck F, et al. (2017). Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer. Carcinogenesis 38, 19-27. doi: 10.1093/carcin/bgw116 | Abstract

Bender S, Gronych J, Warnatz HJ, Hutter B, Gröbner S, Ryzhova M, Pfaff E, Hovestadt V, Weinberg F, Halbach S, et al. (2016). Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nat Med 22, 1-9. doi:10.1038/nm.4204 | Abstract

Dieckmann A, Babin V, Harari Y, Eils R, König R, Luke B & Kupiec M (2016) Role of ESCRT complexes in telomere biology. MBio 7, e01793-16. doi: 10.1128/mBio.01793-16 | Abstract

Deeg KI, Chung I, Bauer C & Rippe K (2016). Cancer cells with alternative lengthening of telomeres do not display a general hypersensitivity to ATR inhibition. Front Oncol 6, 186. doi: 10.3389/fonc.2016.00186 | Abstract

Eck S, Wörz S, Müller-Ott K, Hahn M, Biesdorf A, Schotta G, Rippe K & Rohr K (2016). A spherical harmonics intensity model for 3D segmentation and 3D shape analysis of heterochromatin foci. Med Image Anal 32,18-31. doi: 10.1016/ | Abstract

Sharma AK, Eils R & König R (2016). Copy number alterartions in enzyme-coding and cancer-causing genes reprogram tumor metabolism. Cancer Res 76, 4058-4067. doi:10.1158/0008-5472.CAN-15-2350 | Abstract

Feuerbach L, Sieverling L Deeg, KI, Ginsbach P, Hutter B, Buchhalter I, Northcott PA, Lichter P, Pfister SM, Jones DT, Rippe K & Brors, B (2016). TelomereHunter: telomere content estimation and characterization from whole genome sequencing data. bioRxiv 065532. doi: 10.1101/065532

Poos AM, Maicher A, Dieckmann A, Oswald M, Eils R, Kupiec M, Luke B & König R (2016). Mixed integer linear programming based machine learning approach identifies regulators of telomerase in yeast. Nucleic Acids Res 44, e93. doi: 10.1093/nar/gkw111 | Abstract.

Ernst A, Jones D., Maass KK, Rode A, Deeg KI, Jebaraj BM, Korshunov A, Hovestadt V, Tainsky MA, Pajtler KW, Bender S, Brabetz S, Gröbner S, Kool M, Devens F, Edelmann J, Zhang C, Castelo-Branco P, Tabori U, Malkin D, Rippe K, Stilgenbauer S, Pfister SM, Zapatka M & Lichter P (2016). Telomere dysfunction and chromothripsis. Int J Cancer 138, 2905-2914. doi: 10.1002/ijc.30033 | Abstract.

Gietzelt M, Höfer T, Knaup-Gregori P, König R, Löpprich M, Poos A & Ganzinger M (2016). The use of tools, modelling methods, data types, and endpoints in systems medicine: a survey on projects of the german e:Med-programme. Stud Helth Technol Inform 228, 670-674. doi:10.3233/978-1-61499-678-1-670 | Abstract

Kluth M, Graunke M, Moller-Koop C, Hube-Magg C, Minner S, Michl U, et al. (2016) Deletion of 18q is a strong and independent prognostic feature in prostate cancer. Oncotarget 7, 86339-49.   | Abstract

Kordaß T, Weber CEM, Oswald M, Ast V, Bernhardt M, Novak D, Utikal J, Eichmüller S & König R (2016). SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Med Genomics 9, 10. doi:10.1186/s12920-016-0170-0 | Abstract

Rippe K & Luke B (2015). TERRA and the state of the telomere. Nat Struct Mol Biol 22, 853-858. doi: 10.1038/nsmb.3078 | Abstract.

Melling N, Thomsen E, Tsourlakis MC, Kluth M, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Wilczak W, Huland H, Simon R, Schlomm T, Steurer S, & Krech T (2015). Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters. Carcinogenesis 36, 1333-1340. doi:10.1093/carcin/bgv137 | Abstract

Mallm, JP & Rippe K (2015). Aurora kinase B regulates telomerase activity via a centromeric RNA in stem cells. Cell Rep 11, 1667-1678. doi: 10.1016/j.celrep.2015.05.015 | Abstract

Osterwald S, Deeg KI, Chung I, Parisotto D, Wörz S, Rohr K, Erfle H & Rippe K (2015). PML induces compaction, partial TRF2 depletion and DNA damage signaling at telomeres and promotes alternative lengthening of telomeres. J Cell Sci 128, 1887-1900. doi: 10.1242/jcs.148296 | Abstract.

Schacht T, Oswald M, Eils R, Eichmüller S & König R (2014). Estimating the activity of transcription factors by the effect on their target genes, Bioinformatics 30, i401-407. doi: 10.1093/bioinformatics/btu446 | Abstract


Selected other publications of project partners relevant for CancerTelSys

to top of page